| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $35K | -30.7% | -59.0% |
| Cost of Revenue | $17K | -97.4% | -98.1% |
| Gross Profit | $18K | -97.0% | -98.7% |
| R&D Expense | $40K | -91.7% | -90.1% |
| SG&A Expense | $844K | +218.1% | +17.4% |
| Operating Income | -$8.6M | -210.4% | -386.9% |
| Net Income | -$8.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.7M | +38.4% | +668.1% |
| Accounts Receivable | $23K | -98.4% | -98.2% |
| Current Assets | $6.0M | -31.9% | +13.1% |
| Total Assets | $7.0M | -22.0% | +25.5% |
| Current Liabilities | $3.1M | -2.5% | -22.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.3M | — | — |
| Investing Cash Flow | -$1K | — | — |
| Financing Cash Flow | $7.9M | — | — |
| -220.7% |
| -433.4% |
| EPS (Basic) | -$3.12 | -38.7% | -0.3% |
| EPS (Diluted) | -$3.12 | -38.7% | -0.3% |
| $3.1M |
| -2.3% |
| -24.3% |
| Stockholders' Equity | $2.5M | -56.6% | +70.1% |